Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
04/2010
04/07/2010EP2170851A1 Modulators of pharmacokinetic properties of therapeutics
04/07/2010EP2170842A1 Protein kinase inhibitors and methods for using thereof
04/07/2010EP2170830A1 Compounds and methods for kinase modulation, and indications therefor
04/07/2010EP2170823A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides
04/07/2010EP2170822A2 Proton acceptor iminium/carbocation-type coupling agents
04/07/2010EP2170814A2 Antibacterial agents
04/07/2010EP2170260A1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres
04/07/2010EP2170066A2 Pesticides and uses thereof
04/07/2010EP2170065A1 Diphenyl substituted alkanes
04/07/2010EP1673368B1 Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes
04/07/2010EP1635818B1 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
04/07/2010EP1551829B1 Novel compounds with antibacterial activity
04/07/2010EP1527050B1 Quinoline derivatives and their use as mycobacterial inhibitors
04/07/2010EP1330446B1 Process for the manufacture of thiazole derivatives with pesticidal activity
04/06/2010US7692029 Star-shaped oligothiophene-arylene derivatives and organic thin film transistors using the same
04/06/2010US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent
04/06/2010US7692022 Using luciferin derivatives for analyzing metabolic activity in animals, cells or in cell-free reaction formulations
04/06/2010US7691889 3-(substituted phenyl)-5-substituted-oxazolidin-2-ones; tuberculosis; e.g. (S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]-4-oxo-4-phenylbutanamide
04/06/2010US7691888 Thiazolyl-dihydro-indazole
04/06/2010US7691856 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
04/06/2010US7691854 Diethyl 2-amino-4-(4-cyanophenyl)-6-methyl-1-(3-methylphenyl)-1,4-dihydro-3,5-pyridine-dicarboxylate; chronic obstructive pulmonary disease, acute coronary syndrome, acute myocardial infarction or development of heart failure
04/06/2010US7691853 Pyrazole compounds useful as protein kinase inhibitors
04/06/2010US7691841 Azetidine derivatives as CCR-3 receptor antagonist
04/06/2010US7691837 e.g. 1-{[1,5-bis(4-cholorophenyl)-2-methylpyrrol-3-yl]methyl}-4-(4-fluoro-phenyl)piperazine; Mycobacterium tuberculosis, drug resistant Mycobacterium tuberculosis, Mycobacterium avium-intracellulare complex, Mycobacterium fortuitum or Mycobacterium kansasi
04/06/2010US7691785 Pyridine-3-ketone compound; plant growth controllers
04/06/2010CA2566108C Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
04/06/2010CA2475137C New heterocyclic oxime derivatives, their preparation process and the pharmaceutical compositions that contain them
04/06/2010CA2453383C Piperidine derivatives as nmda receptor antagonists
04/06/2010CA2397636C Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
04/06/2010CA2252536C Ethylene derivatives and pesticides containing said derivatives
04/01/2010WO2010037129A1 Quinazolinone, quinolone and related analogs as sirtuin modulators
04/01/2010WO2010036873A1 2-[1H-Benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
04/01/2010WO2010036638A2 Compounds for the treatment of inflammatory disorders
04/01/2010WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient
04/01/2010WO2010035727A1 Novel pyrrolinone derivative and medicinal composition containing same
04/01/2010WO2010034838A2 New chemical compounds
04/01/2010WO2010034796A1 1h-benz imidazole-5-carboxamides as anti-inflammatory agents
04/01/2010WO2010034105A1 Hepatitis c inhibitor compounds
04/01/2010WO2009131669A3 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
04/01/2010WO2009062576A8 Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
04/01/2010US20100081695 2-N-{5-[ [4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
04/01/2010US20100081693 Thiadiazole compound and use thereof
04/01/2010US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter
04/01/2010US20100081668 Polymorphs of 5--6-chloro-1,3-dihydro-2h-indol-2-one hydrobromide and processes for preparation thereof
04/01/2010US20100081657 Quinoxalines useful as inhibitors of protein kinases
04/01/2010US20100081653 2-[1H-Benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
04/01/2010US20100081650 Antimicrobial Compounds
04/01/2010US20100081644 Compounds Which Selectively Modulate The CB2 Receptor
04/01/2010CA2738809A1 Quinazolinone, quinolone and related analogs as sirtuin modulators
04/01/2010CA2738448A1 New chemical compounds
04/01/2010CA2738083A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents
04/01/2010CA2737958A1 Hepatitis c inhibitor compounds
04/01/2010CA2734472A1 2-[1h-benzimidazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
03/2010
03/31/2010EP2168962A2 Phenylacetamides and their use as glucokinase modulators
03/31/2010EP2168948A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
03/31/2010EP2167497A2 Heterocyclic compounds useful as raf kinase inhibitors
03/31/2010EP2167496A2 Azo dyes
03/31/2010EP2167491A1 5-heteroaryl substituted indazoles as kinase inhibitors
03/31/2010EP2167484A2 Condensed anthranilamide insecticides
03/31/2010EP2167083A2 Novel 1- heteroaryl-3-azabicycloý3.1.0¨hexanes, methods for their preparation and their use as medicaments
03/31/2010EP2166854A1 Triazole derivatives for treating alzheimer's disease and related conditions
03/31/2010EP2166846A1 Inhibitors of janus kinases
03/31/2010EP1716128B1 Substituted 4,5,6,7-tetrahydro-benzothiazol-2-ylamine compounds
03/31/2010EP1620091B1 Inhibitors of glutaminyl cyclase
03/31/2010EP1546107B1 Cox-2 inhibiting pyridine derivatives
03/31/2010EP1252139B1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
03/31/2010CN101687863A Amino-thiazolyl- pyrimidine derivatives and their use for the treatment of cancer
03/31/2010CN101687857A Pyridazinone derivates
03/31/2010CN101687855A Phthalazinone derivatives and their use as medicament to treat cancer
03/31/2010CN101687852A Thiazoles and pyrazoles useful as kinase inhibitors
03/31/2010CN101687846A oxime ester photoinitiators
03/31/2010CN101687845A Isothiazole and pyrazole derivatives as fungicides
03/31/2010CN101687836A Novel microbiocides
03/31/2010CN101687827A aminodihydrothiazine derivatives substituted with cyclic groups
03/31/2010CN101687821A protein kinase inhibitors and methods for using thereof
03/31/2010CN101687816A Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
03/31/2010CN101687813A 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests
03/31/2010CN101687786A Hydroxylamine compounds and methods of their use
03/31/2010CN101684116A Isoniazid lipid derivate and compositions thereof
03/31/2010CN101684095A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/30/2010US7687664 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it
03/30/2010US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
03/30/2010US7687640 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde; inhibits production of A beta 40 and A beta 42 from amyloid precursor protein ; Alzheimer's disease and Down syndrome
03/30/2010US7687637 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors
03/30/2010US7687625 Antidiabetic agents; obesity; controlling appetite
03/30/2010US7687533 N-(1-arylpyrazol-4l) sulfonamides and their use as parasiticides
03/30/2010US7687510 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
03/30/2010US7687508 Cyclic derivatives as modulators of chemokine receptor activity
03/30/2010US7687504 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxo-ethylamino]-1-oxo-propyl]-4-[bis-(4-fluorophenyl)methyl]piperazine; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
03/30/2010US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders
03/30/2010US7687502 Substituted quinazoline or pyridopyrimidine derivative
03/30/2010US7687501 fused tricyclic compounds useful as metabotropic glutamate receptor (mGluR) antagonists, particularly as selective metabotropic glutamate receptor 1 antagonists
03/30/2010US7687492 1,2,4-Oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
03/30/2010US7687490 2-thioethenyl substituted carbapenem derivatives
03/30/2010US7687067 combating phytopathogenic fungi
03/30/2010CA2506983C Ca ix-specific inhibitors
03/30/2010CA2445395C Heterocyclic compound and antitumor agent comprising the same as effective component
03/30/2010CA2428184C Thiazolylphenylcarbamoylmethyl amide derivative
03/25/2010WO2010033977A2 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
03/25/2010WO2010033647A2 Cysteine labeling system and method of use thereof